BHMT Antibodies

Santa Cruz Biotechnology delivers a wide array of BHMT monoclonal antibodies for investigating Betaine-Homocysteine Methyltransferase (BHMT). BHMT monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Betaine-Homocysteine Methyltransferase is a crucial enzyme involved in the metabolism of homocysteine, converting it to methionine using betaine as a methyl donor. The conversion process maintains proper homocysteine levels, which are linked to cardiovascular health and neurological function. Dysregulation of BHMT activity can lead to elevated homocysteine levels, associated with various health issues. BHMT has emerged as an important target for research in metabolic disorders. Research utilizing BHMT monoclonal antibodies has revealed significant insights into homocysteine metabolism and its impact on human health. Ongoing studies continue to uncover new aspects of BHMT function in cellular processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of metabolic pathways and their role in human health.